South San Francisco / Orlando / Edmonton / Seattle / Geelong / Leuven / Copenhagen / Herlev / Basel / Edinburgh / /
Company
NanoString Technologies / Sentinel / M2 Communications Inc. / BEATRICE / ITT / The Breast International Group / Cox / F. Hoffmann-La Roche Ltd / Genentech Inc. / /
Country
Switzerland / Belgium / United States / Canada / Australia / United Kingdom / Singapore / Denmark / /
Currency
pence / /
Event
FDA Phase / Product Recall / Product Issues / /
Facility
University of British Columbia / Andrew Love Cancer Centre / National Cancer Center / University of Edinburgh / Herlev University Hospital / Vesalius Research Center / Cross Center Institute / University of Toronto / University of Pittsburgh Cancer Institute / /
IndustryTerm
treatment of ER-positive advanced breast cancer / cancer therapy / therapy for node-positive breast cancer / breast cancer care / intrinsic subtyping algorithm / /
MedicalCondition
node-positive breast cancer / gastric cancer / invasive ductal carcinoma / basal-like breast cancer / Patients With Advanced Breast Cancer Higher-dose / leukopenia / advanced basal-like breast cancer / ductal carcinoma / Uncomplicated neutropenia / metastatic disease / Metastatic Breast Cancer / endometrial cancer / positive advanced breast cancer / B tumor / primary breast tumor / advanced breast cancer / breast cancer / pancreatic cancer / tumor / measurable disease / cancer / lymphedema / tumors / disease / triplenegative early breast cancer / highly proliferating tumors / both lobular and ductal carcinoma / lobular disease / HR+ breast cancer / invasive breast cancer / ER-positive/HER2-negative breast cancer / stable disease / nodal disease / Lobular Carcinoma / /
MedicalTreatment
adjuvant chemotherapy / endocrine therapy / chemotherapy / Hormone Therapy / surgery / cancer therapy / adjuvant therapy / /
Organization
National Cancer Center / University of Toronto / Toronto / Vesalius Research Center / Cross Center Institute / University of British Columbia / Vancouver / Andrew Love Cancer Centre / Medicare / Herlev University Hospital / University of Edinburgh / Sunnybrook Health Sciences Center / University of Pittsburgh Cancer Institute / Pittsburgh / NHS / /
Person
Angelo Di Leo / Otto Metzger-Filho / Richard S. Finn / Judy Boughey / Richard Gray / Peter Ravdin / William E. Barlow / Dalliah M. Black / John Yarnold / /
“An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer.” D -, 0 0